These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35949616)

  • 1. The mechanism underlying resistance to 5-fluorouracil and its reversal by the inhibition of thymidine phosphorylase in breast cancer cells.
    Mori R; Ukai J; Tokumaru Y; Niwa Y; Futamura M
    Oncol Lett; 2022 Sep; 24(3):311. PubMed ID: 35949616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells.
    Mori R; Yoshida K; Futamura M; Suetsugu T; Shizu K; Tanahashi T; Tanaka Y; Matsuhashi N; Yamaguchi K
    Gastric Cancer; 2019 May; 22(3):497-505. PubMed ID: 30276573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines.
    Suetsugu T; Mori R; Futamura M; Fukada M; Tanaka H; Yasufuku I; Sato Y; Iwata Y; Imai T; Imai H; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yoshida K
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of thymidine phosphorylase in the induction of early growth response protein-1 and thrombospondin-1 by 5-fluorouracil in human cancer carcinoma cells.
    Matsushita S; Ikeda R; Nishizawa Y; Che XF; Furukawa T; Miyadera K; Tabata S; Ushiyama M; Tajitsu Y; Yamamoto M; Takeda Y; Minami K; Mataki H; Kanzaki T; Yamada K; Kanekura T; Akiyama S
    Int J Oncol; 2010 May; 36(5):1193-200. PubMed ID: 20372793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5FU resistance caused by reduced fluoro-deoxyuridine monophosphate and its reversal using deoxyuridine.
    Mori R; Futamura M; Tanahashi T; Tanaka Y; Matsuhashi N; Yamaguchi K; Yoshida K
    Oncol Lett; 2017 Sep; 14(3):3162-3168. PubMed ID: 28927061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and biochemical modulation of 5-fluorouracil through the overexpression of thymidine kinase: an in-vitro study.
    Fanciullino R; Evrard A; Cuq P; Giacometti S; Peillard L; Mercier C; Aubert C; Milano G; Ciccolini J
    Anticancer Drugs; 2006 Apr; 17(4):463-70. PubMed ID: 16550005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.
    Peters GJ; Braakhuis BJ; de Bruijn EA; Laurensse EJ; van Walsum M; Pinedo HM
    Br J Cancer; 1989 Mar; 59(3):327-34. PubMed ID: 2522792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU.
    Liu J; Skradis A; Kolar C; Kolath J; Anderson J; Lawson T; Talmadge J; Gmeiner WH
    Nucleosides Nucleotides; 1999 Aug; 18(8):1789-802. PubMed ID: 10478484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of thymidine phosphorylase expression by Taxol does not enhance Furtulon sensitivity in a cisplatin-resistant human ovarian carcinoma cell line.
    Hata K; Osaki M; Kanasaki H; Nakayama K; Fujiwaki R; Ito H; Miyazaki K
    Anticancer Res; 2003; 23(2B):1525-31. PubMed ID: 12820419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil.
    Hahnvajanawong C; Chaiyagool J; Seubwai W; Bhudhisawasdi V; Namwat N; Khuntikeo N; Sripa B; Pugkhem A; Tassaneeyakul W
    World J Gastroenterol; 2012 Aug; 18(30):3955-61. PubMed ID: 22912546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo.
    Fukushima M; Fujioka A; Uchida J; Nakagawa F; Takechi T
    Eur J Cancer; 2001 Sep; 37(13):1681-7. PubMed ID: 11527696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of 5-fluorouracil-resistant gastric cancer cells.
    Chung YM; Park S; Park JK; Kim Y; Kang Y; Yoo YD
    Cancer Lett; 2000 Oct; 159(1):95-101. PubMed ID: 10974411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitro.
    Mader RM; Sieder AE; Braun J; Rizovski B; Kalipciyan M; Mueller MW; Jakesz R; Rainer H; Steger GG
    Biochem Pharmacol; 1997 Dec; 54(11):1233-42. PubMed ID: 9416974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2
    Yi J; Chen S; Yi P; Luo J; Fang M; Du Y; Zou L; Fan P
    Oncol Res; 2020 Dec; 28(5):519-531. PubMed ID: 32727638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells.
    Inaba M; Mitsuhashi J; Sawada H; Miike N; Naoe Y; Daimon A; Koizumi K; Tsujimoto H; Fukushima M
    Jpn J Cancer Res; 1996 Feb; 87(2):212-20. PubMed ID: 8609072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
    Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
    Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between p53 status and 5-fluorouracil sensitivity in 3 cell lines.
    Oka H; Ikeda K; Yoshimura H; Ohuchida A; Honma M
    Mutat Res; 2006 Jul; 606(1-2):52-60. PubMed ID: 16584912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibition.
    Bijnsdorp IV; Comijn EM; Padron JM; Gmeiner WH; Peters GJ
    Oncol Rep; 2007 Jul; 18(1):287-91. PubMed ID: 17549381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil.
    Mizutani Y; Nakanishi H; Yoshida O; Fukushima M; Bonavida B; Miki T
    Eur J Cancer; 2002 Jan; 38(1):167-76. PubMed ID: 11750847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites.
    Pratt S; Shepard RL; Kandasamy RA; Johnston PA; Perry W; Dantzig AH
    Mol Cancer Ther; 2005 May; 4(5):855-63. PubMed ID: 15897250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.